These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22023206)

  • 21. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
    Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro and In Vivo Evaluation of Carbopol 71G NF-Based Mucoadhesive Minitablets as a Gastroretentive Dosage Form.
    Rump A; Tetyczka C; Littringer E; Kromrey ML; Bülow R; Roblegg E; Weitschies W; Grimm M
    Mol Pharm; 2023 Mar; 20(3):1624-1630. PubMed ID: 36705398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release.
    Zou H; Jiang X; Kong L; Gao S
    J Pharm Sci; 2008 Jan; 97(1):263-73. PubMed ID: 17803198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroretentive Drug Delivery System in Cancer Chemotherapy.
    Anothra P; Pradhan D; Halder J; Ghosh G; Rath G
    Curr Drug Deliv; 2023; 20(5):483-496. PubMed ID: 35676836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric retentive dosage forms: a review.
    Hou SY; Cowles VE; Berner B
    Crit Rev Ther Drug Carrier Syst; 2003; 20(6):459-97. PubMed ID: 14979868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.
    Whitehead L; Fell JT; Collett JH; Sharma HL; Smith A
    J Control Release; 1998 Oct; 55(1):3-12. PubMed ID: 9795000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer.
    Garg T; Kumar A; Rath G; Goyal AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(6):531-57. PubMed ID: 25271775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.
    Nila MV; Sudhir MR; Cinu TA; Aleykutty NA; Jose S
    Drug Deliv; 2014 Mar; 21(2):110-7. PubMed ID: 24028280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.
    Pawar VK; Kansal S; Garg G; Awasthi R; Singodia D; Kulkarni GT
    Drug Deliv; 2011 Feb; 18(2):97-110. PubMed ID: 20958237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation of zein based compression coated floating tablets for enhanced gastric retention and tunable drug release.
    Raza A; Shen N; Li J; Chen Y; Wang JY
    Eur J Pharm Sci; 2019 Apr; 132():163-173. PubMed ID: 30695689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
    Pahwa R; Saini N; Kumar V; Kohli K
    Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.
    Eisenächer F; Garbacz G; Mäder K
    Eur J Pharm Biopharm; 2014 Nov; 88(3):778-86. PubMed ID: 25086221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles.
    Mastiholimath VS; Dandagi PM; Gadad AP; Mathews R; Kulkarni AR
    J Microencapsul; 2008 Aug; 25(5):307-14. PubMed ID: 18465300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery to the upper small intestine window using gastroretentive technologies.
    Streubel A; Siepmann J; Bodmeier R
    Curr Opin Pharmacol; 2006 Oct; 6(5):501-8. PubMed ID: 16890020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.
    Singh BN; Kim KH
    J Control Release; 2000 Feb; 63(3):235-59. PubMed ID: 10601721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
    Qi X; Jiang Y; Zhang H; Wu Z
    J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of gastroretentive drug delivery system for cefuroxime axetil: in vitro and in vivo evaluation in human volunteers.
    Bomma R; Veerabrahma K
    Pharm Dev Technol; 2013; 18(5):1230-7. PubMed ID: 22348334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of gastroretentive floating tablets of Silymarin.
    Garg R; Gupta GD
    Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric nanofibers: targeted gastro-retentive drug delivery systems.
    Malik R; Garg T; Goyal AK; Rath G
    J Drug Target; 2015 Feb; 23(2):109-24. PubMed ID: 25268275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.
    Ozdemir N; Ordu S; Ozkan Y
    Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.